Literature DB >> 15362366

Gleason grading of prostate cancer: level of concordance between pathologists at the University Hospital of the West Indies.

Kathleen C Coard1, Vincent L Freeman.   

Abstract

Our aim was to study the level of interobserver concordance in the Gleason scores of prostate needle biopsy specimens reported at 1 institution. A retrospective review of all prostate needle biopsy specimens in which a diagnosis of adenocarcinoma was made during the year 2000 was conducted. Parameters evaluated included the Gleason score, Gleason grades identified, the percentage of Gleason grades 4 and 5, and the percentage of tumor in the biopsy specimen. Our results demonstrated a 60% overall concordance in consensus Gleason scores, which increased to 80% when considered in groups of a Gleason score of less than 7 vs 7 or more. The greatest discordance seemed to be in distinguishing Gleason score 6 from 7 and was more frequent among biopsy specimens with lower tumor volumes, particularly among those with less than 30% involvement. A small percentage of Gleason grade 4 pattern might predict disagreement as well. Strategies for improving accuracy of Gleason score 7 should be devised, and consensus diagnosis for biopsy specimens that demonstrate a low percentage of tumor volume is recommended.

Entities:  

Mesh:

Year:  2004        PMID: 15362366     DOI: 10.1309/3A32-DTVM-H640-M2QA

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Frequency and determinants of disagreement and error in gleason scores: a population-based study of prostate cancer.

Authors:  Michael Goodman; Kevin C Ward; Adeboye O Osunkoya; Milton W Datta; Daniel Luthringer; Andrew N Young; Katerina Marks; Vaunita Cohen; Jan C Kennedy; Michael J Haber; Mahul B Amin
Journal:  Prostate       Date:  2012-01-06       Impact factor: 4.104

2.  The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy.

Authors:  Christian Arsov; Nikolaus Becker; Robert Rabenalt; Andreas Hiester; Michael Quentin; Frederic Dietzel; Gerald Antoch; Helmut E Gabbert; Peter Albers; Lars Schimmöller
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-27       Impact factor: 4.553

3.  Review by urological pathologists improves the accuracy of Gleason grading by general pathologists.

Authors:  Yasushi Nakai; Nobumichi Tanaka; Keiji Shimada; Noboru Konishi; Makito Miyake; Satoshi Anai; Kiyohide Fujimoto
Journal:  BMC Urol       Date:  2015-07-23       Impact factor: 2.264

4.  Histopathological spectrum of 364 prostatic specimens including immunohistochemistry with special reference to grey zone lesions.

Authors:  Monika Garg; Gurmeen Kaur; Vineeta Malhotra; Ravish Garg
Journal:  Prostate Int       Date:  2013-12-30

5.  PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis.

Authors:  Sara Bravaccini; Maurizio Puccetti; Martine Bocchini; Sara Ravaioli; Monica Celli; Emanuela Scarpi; Ugo De Giorgi; Maria Maddalena Tumedei; Giandomenico Raulli; Loredana Cardinale; Giovanni Paganelli
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

6.  Pathological upgrading and upstaging at radical prostatectomy in Jamaican men with low-risk prostate cancer.

Authors:  Belinda F Morrison; William D Aiken; Gareth Reid; Richard Mayhew; Barrie Hanchard
Journal:  Ecancermedicalscience       Date:  2019-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.